about
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectLigand self-recognition in the stereoselective assembly of [2 + 2] metallomacrocycles from racemic chiral bisbipyridyl molecular clefts and zinc(II).Discriminating lymphomas and reactive lymphadenopathy in lymph node biopsies by gene expression profilingRationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectExpression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions.Metabolic profiling and flux analysis of MEL-2 human embryonic stem cells during exponential growth at physiological and atmospheric oxygen concentrationsOne-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.The role of molecular studies in lymphoma diagnosis: a review.Xanthomatous pituitary lesions: a report of two cases and review of the literature.Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.Diagnostic pathology of lymphoproliferative disorders.Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumMeta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia.Applications of type I antifreeze proteins: studies with model membranes & cryoprotectant properties.Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure.Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.Optimization of flowrate for expansion of human embryonic stem cells in perfusion microbioreactors.Atopy, exposure to pesticides and risk of non-Hodgkin lymphoma.Birth order, atopy, and risk of non-Hodgkin lymphoma.Myonecrosis of the middle cerebral artery with thrombosis and cerebral infarction following resection of meningioma.A histopathologic review of temporal bone exostoses and osteomata.Primary intestinal Hodgkin's disease complicating ileal Crohn's disease.Chondromyxoid fibroma of the skull base.Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis.Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults.Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.Extraprostatic extension (EPE) of prostatic carcinoma: is its proximity to the surgical margin or Gleason score important?Risk of non-Hodgkin lymphoma associated with occupational exposure to solvents, metals, organic dusts and PCBs (Australia).Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.Histopathological and clinical evaluation of serrated adenomas of the colon and rectum.Triton tumor.Cerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT.Squamous cell carcinoma of the internal auditory canal.Renal carcinoma metastasis: an unusual cerebellopontine angle tumor.Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011.Extensive facial nerve tumor with atypical histology: case report.Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
P50
Q28393769-A017BF7C-8453-4AFF-94C2-1399A4157E41Q31093037-7A1F571E-C692-4B35-B263-83630A0F6EF2Q33858819-F8A48BC0-73A0-40AB-B880-BC8E80096219Q34137915-4AD76D06-E70D-481F-ADD5-B3DF959EFE15Q34227851-52E4AD55-F7BB-405D-AA04-528B40F34981Q34360414-D1BBF70B-145C-4562-9953-EBD0FDFF5A85Q34549776-6FC5913C-C0DC-4997-9E95-1E5A72D2BE33Q34692324-F062E1C2-51DE-4C80-90D9-AE72BABE9813Q35646351-2B33827A-C5BA-4C21-B94A-F9C773A8683CQ35670505-FF8F0AFE-55B5-4389-A839-C9BE25C2F129Q36120539-704BA644-A9F1-411E-B519-1F13E37012B7Q36350754-25BDB662-C4DE-4EFF-88C3-5EECAA9060A9Q36528740-0F0C1E6A-7EA1-4B7A-8426-6DCB25486D96Q36675182-2CB5A087-492A-4BF3-9F57-195A5291F501Q36683712-425588FA-BD7B-4D14-B056-17D2EE7FACC5Q37378472-C9C83447-D671-4655-B45F-7F6F18890BEAQ37944906-1E24A0B9-E760-43B3-B5F1-6C7401B2F835Q38427810-6B508DAD-BF70-47C6-B86A-9DFA1F43D953Q38858888-0B9AA791-E636-46FB-8F38-F6CD41EEB459Q39512168-8538268E-6DF7-49B9-BE8A-05A5D621D133Q40458179-952A8110-26B4-4691-89A2-6E362CEC3D07Q40510360-F56492E3-6DCA-4DC9-9929-31650B3AFBEFQ40743936-ACA0423E-F560-4282-8587-52F7B0115FE8Q40985180-4BB25D53-7A8D-463C-8A67-860DC97D5C88Q41543678-2954669E-CAB9-4662-99E3-CDC81F8B6C2DQ41732166-78B19901-2CF9-48C1-9DE0-0D7F4FECF710Q42911640-046E7A73-3995-433A-B725-D7533FA68E45Q43220741-53DDDACD-C7CA-4E18-9330-E3677466FE7DQ43976161-3297AB52-8772-4E08-83DF-EC95243E9E4CQ45750299-26E0E88D-1F70-4653-A575-2DAB98B5C50FQ46573357-EE605AE2-EEFB-465D-8E10-33A1F6C259ACQ47887723-0723B398-AFA1-42D1-8CDE-6D82B0E44D6FQ47911861-148048A9-71A3-4332-B79F-9607CC89C54BQ48222848-8F1C14E0-DD53-4275-AE75-A01E106084F9Q48378386-75F800BF-5343-4155-9AA8-BF036A0EDE3EQ48435580-CB592FAB-3DA3-4F75-A8CF-3C5CEFD628C6Q48481101-386BC2EC-D1BA-43C1-971F-0BCA898EF37DQ50431817-4837CCEE-963A-444B-A569-71B28AC50222Q50524933-CAF32B9D-6857-4CEA-8AB1-7D86D2654BE4Q51242022-C91CE994-BD3C-4D30-829A-F96D22E3BA0C
P50
description
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Jennifer Turner
@ast
Jennifer Turner
@en
Jennifer Turner
@es
Jennifer Turner
@nl
Jennifer Turner
@sl
type
label
Jennifer Turner
@ast
Jennifer Turner
@en
Jennifer Turner
@es
Jennifer Turner
@nl
Jennifer Turner
@sl
altLabel
Turner J
@en
prefLabel
Jennifer Turner
@ast
Jennifer Turner
@en
Jennifer Turner
@es
Jennifer Turner
@nl
Jennifer Turner
@sl
P106
P1153
35547531800
P21
P31
P496
0000-0001-5550-3375